SCHEMBL3592317

SCHEMBL3592317

O=C(Cn1ccc2cccc(-c3cccnc3)c21)NCCNCC1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
RAB9A P51151 1/20 0.41
LMNA P02545 1/20 0.38
NTSR1 P30989 1/20 0.38
BMP1 P13497 1/20 0.38
EGLN1 Q9GZT9 1/20 0.38
GBA1 P04062 1/20 0.38
CNR1 P21554 2/20 0.37
CNR2 P34972 1/20 0.37
ALDH1A1 P00352 3/20 0.37
HSD17B10 Q99714 2/20 0.37
MAPK1 P28482 1/20 0.37
KCNH2 Q12809 1/20 0.37
ATM Q13315 1/20 0.37
ATR Q13535 1/20 0.37
NAMPT P43490 1/20 0.37
TSHR P16473 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
NPY5R Q15761 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3596540 0.92 HSD17B10 (0.37) KDM4ERAB9ALMNABMP1CNR1
SCHEMBL3589653 0.91 ROCK2 (0.38) KDM4ELMNACNR1CNR2ALDH1A1
SCHEMBL3597289 0.90 ALDH1A1 (0.41) KDM4ERAB9ALMNAALDH1A1HSD17B10
SCHEMBL3605994 0.85 PIM1 (0.42) KDM4ERAB9AALDH1A1HSD17B10MAPK1
SCHEMBL3608260 0.85 GRIN2B (0.42) KDM4ERAB9ALMNACNR2ALDH1A1
SCHEMBL3608180 0.85 HTT (0.45) KDM4ERAB9ALMNACNR1CNR2
SCHEMBL3594707 0.85 NPC1 (0.41) KDM4ERAB9ALMNACNR1ALDH1A1
SCHEMBL3595323 0.83 ALDH1A1 (0.44) KDM4EALDH1A1HSD17B10MAPK1TSHR
SCHEMBL3597445 0.83 KDM4E (0.45) KDM4ERAB9ALMNAALDH1A1HSD17B10
SCHEMBL3592315 0.83 GAA (0.42) KDM4ERAB9ANTSR1EGLN1GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 KDM4E 4801/4885RAB9A 602/4885LMNA 4638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.